Live Breaking News & Updates on கிராபிக்ஸ்

Stay updated with breaking news from கிராபிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Factbox-Latest on the worldwide spread of the coronavirus


By Reuters Staff
4 Min Read
(Reuters) - The World Health Organization is seeking to fill the gap left in the COVAX dose-sharing programme by India suspending exports of AstraZeneca doses and is in talks with donors including the United States, senior WHO officials said.
FILE PHOTO: Volunteers prepare to cremate the body of a person who died due to the coronavirus disease (COVID-19), at a crematorium ground in Giddenahalli village on the outskirts of Bengaluru, India, May 2, 2021. REUTERS/Samuel Rajkumar
DEATHS AND INFECTIONS
EUROPE
Novavax has told the European Union it plans to begin delivering its COVID-19 vaccine to the bloc towards the end of this year, new guidance that could lead to a formal contract being signed as early as this week, an EU official told Reuters. ....

New York , United States , United Kingdom , White House , District Of Columbia , Albert Bourla , Federico Maccioni , Joe Biden , Budi Gunadi Sadikin , Mehmet Ersoy , Veronica Snoj , Boris Johnson , Jens Spahn , Thomson Reuters Trust Principles , World Health Organization , European Union , Health Minister Jens Spahn , Prime Minister Boris Johnson , Health Minister Budi Gunadi Sadikin , Culture Minister Mehmet Ersoy , Thomson Reuters Trust , Corona Virus , United Arab Emirates , Asia Pacific , Bio Therapeutic Drugs Trbc Level 5 , Content Produced In Bangalore ,

Supply chain bottlenecks amid roaring demand slow U.S. manufacturing


6 Min Read
WASHINGTON (Reuters) - U.S. manufacturing activity grew at a slower pace in April, restrained by shortages of inputs as rising vaccinations against COVID-19 and massive fiscal stimulus unleashed pent-up demand.
FILE PHOTO: A worker pours hot metal at the Kirsh Foundry in Beaver Dam, Wisconsin, U.S., April 12, 2018. REUTERS/Timothy Aeppel
The survey from the Institute for Supply Management (ISM) on Monday showed record-long lead times, wide-scale shortages of critical basic materials, rising commodities prices and difficulties in transporting products across industries.
The pandemic, now in its second year, has severely disrupted supply chains. The ISM noted that “companies and suppliers continue to struggle to meet increasing rates of demand due to coronavirus impacts limiting availability of parts and materials.” It cautioned that worker absenteeism, short-term shutdowns due to part shortages and difficulties in filling open positions could limit ma ....

New York , United States , North Carolina , White House , District Of Columbia , Jerome Powell , Chizu Nomiyama , Donald Trump , Andrea Ricci , Tim Quinlan , Joel Naroff , Lucia Mutikani , Thomson Reuters Trust Principles , Ford Motor Co , Federal Reserve , Commerce Department , Wells Fargo , Institute For Supply Management , Supply Management , Will Compernolle , Reserve Chair Jerome Powell , Naroff Economics , President Donald Trump , Thomson Reuters Trust , Construction Data , Economic Indicators ,

Scientists, doctors slam Hungarian government criticism of western vaccines


4 Min Read
BUDAPEST (Reuters) - Hungarian scientists and doctors have warned against relying on numbers released by the government that suggested Russian and Chinese COVID-19 shots were more effective than Western ones, the latest twist in the country’s unorthodox vaccine rollout.
FILE PHOTO: People wearing protective face masks walk in downtown Budapest, after Hungarian government imposed a nationwide lockdown to contain the spread of the coronavirus disease (COVID-19), Hungary, November 11, 2020. REUTERS/Bernadett Szabo/Files
Hungary is the only European Union country to authorise and deploy Russian and Chinese jabs before they have been approved by the EU drugs regulator, while Prime Minister Viktor Orban has cultivated strong ties with both Russia and China. ....

New York , United States , David Gregorio , Ludwig Burger , Josephine Mason , Tamas Ferenci , Polina Ivanova , Marton Dunai , John Miller , Viktor Orban , Thomson Reuters Trust Principles , Us Centers For Disease , Obuda University , Hungarian Medical Chamber , European Union , Prime Minister Viktor Orban , Disease Control , Michael Erman , Thomson Reuters Trust , Corona Virus , Asia Pacific , Company News , China Prc , Diplomacy Foreign Policy , Health Medicine , Healthcare Trbc Level 1 ,

Analysis: Bent on reviving growth, CEE countries shun near-term inflation threat


6 Min Read
BUDAPEST/PRAGUE (Reuters) - Central Europe’s rate setters for the most part look set to weather a looming spike in inflation and let their economies rebound with a vengeance from the COVID-19 shutdown, propelled by strong domestic demand, investments and European Union funds.
FILE PHOTO: People enjoy the evening outside a bar after the Hungarian government allowed the reopening of outdoor terraces, as the spread of the coronavirus disease (COVID-19) continues in Budapest, Hungary, April 24, 2021. REUTERS/Bernadett Szabo/File Photo
The EU’s eastern members, whose job markets and wage growth have remained buoyant, are facing higher inflationary pressures than others in Europe. ....

Czech Republic , Jiri Rusnok , David Evans , Peter Virovacz , Adam Glapinski , Arvind Ramakrishnan , Alan Charlish , Viktor Orban , Thomson Reuters Trust Principles , National Bank , Fitch Ratings , European Union , Czech National Bank , Prime Minister Viktor Orban , Thomson Reuters Trust , East Europe , Central Eastern Europe , Central Banks Bank Events , Currency Intervention , Debt Fixed Income Markets , East European Countries , Emerging Market Countries , Enterprise Reporting , Currencies Foreign Exchange Markets , Economic Output , Government Finances ,

World to spend $157 billion on COVID-19 vaccines through 2025 - report


3 Min Read
FILE PHOTO: A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
(Reuters) - Total global spending on COVID-19 vaccines is projected to reach $157 billion by 2025, driven by mass vaccination programs underway and “booster shots” expected every two years, according to a report by U.S. health data company IQVIA Holdings Inc released on Thursday.
IQVIA, which provides data and analytics for the healthcare industry, said it expects the first wave of COVID-19 vaccinations to reach about 70% of the world’s population by the end of 2022. Booster shots are likely to follow initial vaccinations every two years, the report said, based on current data on the duration of effect of the vaccines. ....

United States , White House , District Of Columbia , Manas Mishra , Murray Aitken , Thomson Reuters Trust Principles , Holdings Inc , Pfizer Inc , Thomson Reuters Trust , Corona Virus , Asia Pacific , Bio Therapeutic Drugs Trbc Level 5 , Content Produced In Bangalore , Company News , Generic Pharmaceuticals Trbc Level 5 , Economic News 3rd Party , United Kingdom , Health Medicine , Healthcare Trbc Level 1 , Hong Kong , Biotechnology Amp Medical Research Trbc Level 4 , Biotechnology Amp Medical Research Nec Trbc Level 5 , Major News , Pharmaceuticals Trbc Level 4 , Pharmaceuticals Nec Trbc Level 5 , Pharmaceuticals Amp Medical Research Trbc Level 2 ,